文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

急性疾病严重程度与COVID-19出院患者一年生活质量的相关性:Coalition VII前瞻性队列研究

Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study.
PubMed 文献 · Intensive Care Med · 2023-01-03
一句话结论住院期间需机械通气的COVID-19幸存者1年生活质量低于不需机械通气者(EQ-5D-3L效用值0.7 vs 0.84)。

该研究为嵌套于5项随机临床试验的前瞻性队列,2020年3月至2022年3月在巴西84个中心纳入1508例成人COVID-19出院患者,随访1年。主要终点为EQ-5D-3L效用值,按住院期间改良序数量表最高分级(2-5分)评估急性疾病严重程度。1年时,与严重程度2分相比,5分与更低的EQ-5D-3L效用值(0.7 vs 0.84;校正差值-0.1[95%CI -0.15至-0.06])及更差的全因死亡、主要心血管事件和新发失能相关;3分和4分与2分无一致差异。结论提示需机械通气的COVID-19患者1年生活质量更低。

要点

  • 与严重程度2分(无需氧疗)相比,5分(机械通气)患者1年EQ-5D-3L效用值更低:0.7 vs 0.84,校正差值-0.1(95%CI -0.15至-0.06)。
  • 5分患者1年全因死亡7.9% vs 2分1.2%,校正差值7.1%(95%CI 2.5%-11.8%)。
  • 5分患者1年主要心血管事件5.6% vs 2分2.3%,校正差值2.6%(95%CI 0.6%-4.6%)。
  • 5分患者1年新发失能40.4% vs 2分23.5%,校正差值15.5%(95%CI 8.5%-22.5%)。
  • 严重程度3分和4分与2分在各项结局上无一致差异。

适用人群与场景

  • 成人COVID-19住院后出院患者,随访1年。
  • 研究嵌套于2020年3月至2022年3月巴西84个中心的5项随机临床试验。

诊断标准与关键阈值

  • 急性疾病严重程度按住院期间改良序数量表最高分级评定:2分=无需氧疗;3分=面罩或鼻导管吸氧;4分=经鼻高流量氧疗或无创通气;5分=机械通气。

研究设计与关键结果

  • 研究类型:前瞻性队列研究,嵌套于5项随机临床试验,巴西84个中心,纳入1508例COVID-19幸存者,主要结局数据可获取1156例。
  • 主要终点:1年时,与严重程度2分相比,5分与更低的EQ-5D-3L效用值相关(0.7 vs 0.84;校正差值-0.1[95%CI -0.15至-0.06])。
  • 次要终点:5分 vs 2分,全因死亡7.9% vs 1.2%(校正差值7.1%[95%CI 2.5%-11.8%]);主要心血管事件5.6% vs 2.3%(校正差值2.6%[95%CI 0.6%-4.6%]);新发失能40.4% vs 23.5%(校正差值15.5%[95%CI 8.5%-22.5%])。
  • 严重程度3分和4分与2分在各项结局上无一致差异。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对住院期间需机械通气的COVID-19幸存者,出院后1年应关注生活质量、全因死亡、主要心血管事件和新发失能风险。
  • 严重程度3分和4分与2分在各项结局上无一致差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To assess the association between acute disease severity and 1-year quality of life in patients discharged after hospitalisation due to coronavirus disease 2019 (COVID-19).

METHODS: We conducted a prospective cohort study nested in 5 randomised clinical trials between March 2020 and March 2022 at 84 sites in Brazil. Adult post-hospitalisation COVID-19 patients were followed for 1 year. The primary outcome was the utility score of EuroQol five-dimension three-level (EQ-5D-3L). Secondary outcomes included all-cause mortality, major cardiovascular events, and new disabilities in instrumental activities of daily living. Adjusted generalised estimating equations were used to assess the association between outcomes and acute disease severity according to the highest level on a modified ordinal scale during hospital stay (2: no oxygen therapy; 3: oxygen by mask or nasal prongs; 4: high-flow nasal cannula oxygen therapy or non-invasive ventilation; 5: mechanical ventilation).

RESULTS: 1508 COVID-19 survivors were enrolled. Primary outcome data were available for 1156 participants. At 1 year, compared with severity score 2, severity score 5 was associated with lower EQ-5D-3L utility scores (0.7 vs 0.84; adjusted difference, - 0.1 [95% CI - 0.15 to - 0.06]); and worse results for all-cause mortality (7.9% vs 1.2%; adjusted difference, 7.1% [95% CI 2.5%-11.8%]), major cardiovascular events (5.6% vs 2.3%; adjusted difference, 2.6% [95% CI 0.6%-4.6%]), and new disabilities (40.4% vs 23.5%; adjusted difference, 15.5% [95% CI 8.5%-22.5]). Severity scores 3 and 4 did not differ consistently from score 2.

CONCLUSIONS: COVID-19 patients who needed mechanical ventilation during hospitalisation have lower 1-year quality of life than COVID-19 patients who did not need mechanical ventilation during hospitalisation.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Rosa RG, Cavalcanti AB, Azevedo LCP, et al. Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study. Intensive Care Med. 2023. PMID: 36594987. doi:10.1007/s00134-022-06953-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。